Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Fulcrum Therapeutics, Inc.
*MAILING ADDRESS
26 Landsdowne Street
*CITY
Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02139
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
042
*IDENTIFICATION
Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Providing information relating to diagnostic, prophylactic
and therapeutic properties of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy;
Pharmaceutical products development; Development of pharmaceutical preparations and medicines
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:97292306
Filing Date:03/02/2022
To the Commissioner for Trademarks:
MARK: FSHD REACH (Standard Characters, see mark)
The literal element of the mark consists of FSHD REACH. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Fulcrum Therapeutics, Inc., a corporation of Delaware, having an address of
26 Landsdowne Street
Cambridge, Massachusetts 02139
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Clinical research in the field of Facioscapulohumeral Muscular Dystrophy/Atrophy; Providing information relating to diagnostic, prophylactic and therapeutic properties
of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for treatment of Facioscapulohumeral Muscular Dystrophy/Atrophy; Pharmaceutical products development;
Development of pharmaceutical preparations and medicines
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The owner's/holder's proposed attorney information: Deborah E. Greaves. Deborah E. Greaves of Withers Bergman LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX,
is located at
10250 Constellation Blvd., Suite 1400
Los Angeles, California 90067
United States
310-277-9930(phone)
310-277-9935(fax)
deborah.greaves@withersworldwide.com
The docket/reference number is 1000077.0012.
Deborah E. Greaves submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /Regina Ciolek/ Date: 03/02/2022
Signatory's Name: Regina Ciolek
Signatory's Position: Associate Director, Patent Attorney
Signatory's Phone Number: 6178709345
Signature method: Sent to third party for signature
Payment Sale Number: 97292306
Payment Accounting Date: 03/02/2022
Serial Number: 97292306
Internet Transmission Date: Wed Mar 02 19:01:55 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XX.XXX.XXX-202203021901554
82456-97292306-820ecbac265284a1464c61b6f
9dac50ed8c942132558e2ea2443afc81c8b1f-DA
-01553788-20220302181409015242